Abstract
In dermatology, photodynamic therapy (PDT) has become a well established treatment modality which has been shown to be effective and safe for many skin and mucosal disorders. Pre-clinical and clinical studies demonstrate that, in addition to the direct local cytotoxicity and vascular effects, PDT can induce various host immune responses. Recent clinical data also show that improved clinical outcomes can be obtained through the sequential use of PDT and immunomodulation. This article will provide an update on the current status of such a combination in dermatological applications.
Similar content being viewed by others
References
I. J. MacDonald and T. J. Dougherty, Basic principle of photodynamic therapy, J. Porphyrins Phthalocyanines, 2001, 5, 105–129.
A. P. Castano, T. N. Demidova and M. R. Hamblin, Mechanisms in photodynamic therapy: Part three–Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction, Photodiagn. Photodyn. Ther., 2005, 2, 91–106.
Z. Huang, H. Xu, A. D. Meyers, A. I. Musani, L. Wang, R. Tagg, A. B. Barqawi and Y. K. Chen, Photodynamic therapy for treatment of solid tumors–potential and technical challenges, Technol. Cancer Res. Treat., 2008, 7, 309–320.
Z. Huang, A review of progress in clinical photodynamic therapy, Technol. Cancer Res. Treat., 2005, 4, 283–294.
Z. Huang, L. Li, H. Wang, X. Wang, K. Yuan, A. D. Meyers, L. Yang and F. W. Hetzel, Photodynamic therapy–an update on clinical applications, J. Innovative Opt. Health Sci., 2009, 2, 73–92.
B. Chen, B. W. Pogue, P. J. Hoopes and T. Hasan, Vascular and cellular targeting for photodynamic therapy, Crit. Rev. Eukaryot. Gene Expr., 2006, 16, 279–305.
U. Schmidt-Erfurth and T. Hasan, Mechanisms of action of photodynamic therapywith verteporfin for the treatment of age-related macular degeneration, Surv. Ophthalmol., 2000, 45, 195–214.
N. M. Bressler, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group, Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degenerationwith verteporfin: two-year results of 2 randomized clinical trials–TAP report 2, Arch. Ophthalmol., 2001, 119, 198–207.
K. H. Yuan, Q. Li, W. L. Yu and Z. Huang, Photodynamic therapy in treatment of port wine stain birthmarks–recent progress, Photodiagn. Photodyn. Ther., 2009, 6, 189–194.
Z. Huang, Q. Chen, K. C. Dole, A. B. Barqawi, Y. K. Chen, D. Blanc, B. C. Wilson and F. W. Hetzel, The effect of Tookad-mediated photodynamic ablation of the prostate gland on adjacent tissues–in vivo study in a canine model, Photochem. Photobiol. Sci., 2007, 6, 1318–1324.
P. Babilas and R. M. Szeimies, The use of photodynamic therapy in dermatology, G. Ital. Dermatol. Venereol., 2010, 145, 613–630.
J. C. Kennedy, R. H. Pottier and D. C. Pross, Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience, J. Photochem. Photobiol., B, 1990, 6, 143–148.
E. H. Tschen, D. S. Wong, D. M. Pariser, F. E. Dunlap, A. Houlihan and M. B. Ferdon, Phase IV ALA-PDT Actinic Keratosis Study Group. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up, Br. J. Dermatol., 2006, 155, 1262–1269.
G. I. Stables, M. R. Stringer, D. J. Robinson and D. V. Ash, Large patches of Bowen’s disease treated by topical aminolaevulinic acid photodynamic therapy, Br. J. Dermatol., 1997, 136, 957–960.
X. L. Wang, H. W. Wang, M. X. Guo and S. Z. Xu, Treatment of skin cancer and pre-cancer using topical ALA-PDT–A single hospital experience, Photodiagn. Photodyn. Ther., 2008, 5, 127–133.
L. R. Braathen, R. M. Szeimies, N. Basset-Seguin, R. Bissonnette, P. Foley, D. Pariser, R. Roelandts, A. M. Wennberg and C. A. Morton, International Society for Photodynamic Therapy in Dermatology, Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology 2005, J. Am. Acad. Dermatol., 2007, 56, 125–143.
E. Sotiriou, Z. Apalla, T. Koussidou-Erremonti and D. Ioannides, Actinic cheilitis treated with one cycle of 5-aminolaevulinic acid-based photodynamic therapy: report of 10 cases, Br. J. Dermatol., 2008, 159, 261–262.
C. S. Souza, A. B. Neves, L. A. Felício, J. Ferreira, C. Kurachi and V. S. Bagnato, Optimized photodynamic therapy with systemic photosensitizer following debulking technique for nonmelanoma skin cancers, Dermatol. Surg., 2007, 33, 194–198.
J. A. Leman, D. C. Dick and C. A. Morton, Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma, Clin. Exp. Dermatol., 2002, 27, 516–518.
A. F. Nikkels, L. Thirion, P. Quatresooz and G. E. Piérard, Photodynamic therapy for cutaneous verrucous carcinoma, J. Am. Acad. Dermatol., 2007, 57, 516–519.
F. Raspagliesi, R. Fontanelli, G. Rossi, A. Ditto, E. Solima, F. Hanozet and S. Kusamura, Photodynamic therapy using a methyl ester of 5-aminolevulinic acid in recurrent Paget’s disease of the vulva: a pilot study, Gynecol. Oncol., 2006, 103, 581–586.
L. Li, Y. Deng, L. Zhang, W. Liao, R. Luo and Z. Huang, Treatment of perianal Paget’s disease using photodynamic therapy with assistance of fluorescence examination: case report, Lasers Med. Sci., 2009, 24, 981–984.
S. Piaserico, A. Belloni Fortina, P. Rigotti, B. Rossi, N. Baldan, M. Alaibac and F. Marchini, Topical photodynamic therapy of actinic keratosis in renal transplant recipients, Transplant Proc., 2007, 39, 1847–1850.
C. M. Perrett, J. M. McGregor, J. Warwick, P. Karran, I. M. Leigh, C. M. Proby and C. A. Harwood, Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy, Br. J. Dermatol., 2007, 156, 320–328.
X. L. Wang, H. W. Wang, L. L Zhang, M. X. Guo and Z. Huang, Topical ALA PDT for the treatment of severe acne vulgaris, Photodiagn. Photodyn. Ther., 2010, 7, 33–38.
M. Horn and P. Wolf, Topical methyl aminolevulinate photodynamic therapy for the treatment of folliculitis, Photodermatol., Photoimmunol. Photomed., 2007, 23, 145–147.
T. Smits, M. M. Kleinpenning, P. E. van Erp, P. C. van de Kerkhof and M. J. Gerritsen, A placebo-controlled randomized study on the clinical effectiveness, immunohistochemical changes and protoporphyrin IX accumulation in fractionated 5-aminolaevulinic acid-photodynamic therapy in patients with psoriasis, Br. J. Dermatol., 2006, 155, 429–436.
V. Schleyer, S. Radakovic-Fijan, S. Karrer, T. Zwingers, A. Tanew, M. Landthaler and R. M. Szeimies, Disappointing results and low tolerability of photodynamic therapy with topical 5-aminolaevulinic acid in psoriasis. A randomized, double-blind phase I/II study, J. Eur. Acad. Dermatol. Venereol., 2006, 20, 823–828.
D. Wilsmann-Theis, T. Bieber and N. Novak, Photodynamic therapy as an alternative treatment for cutaneous sarcoidosis, Dermatology, 2008, 217, 343–346.
P. Weisenseel, A. V. Kuznetsov, S. Molin, T. Ruzicka, C. Berking and J. C. Prinz, Photodynamic therapy for granuloma annulare:More than a shot in the dark, Dermatology, 2008, 217, 329–332.
R. Batchelor, S. Lamb, V. Goulden, G. Stables, M. Goodfield and W. Merchant, Photodynamic therapy for the treatment of morphoea, Clin. Exp. Dermatol., 2008, 33, 661–663.
X. L. Wang, H. W. Wang, H. S. Wang, S. Z. Xu, K. H. Liao and P. Hillemanns, Topical 5-aminolaevulinic acid-photodynamic therapy for the treatment of urethral condylomata acuminate, Br. J. Dermatol., 2004, 151, 880–885.
K. Chen, B. Z. Chang, M. Ju, X. H. Zhang and H. Gu, Comparative study of photodynamic therapy vs. CO2 laser vaporization in treatment of condylomata acuminata: a randomized clinical trial, Br. J.Dermatol., 2007, 156, 516–520.
X. L. Wang, H. W. Wang, Z. Huang, H. Stepp, R. Baumgartner, C. Dannecker and P. Hillemanns, Study of protoporphyrin IX (PpIX) pharmacokinetics after topical application of 5-aminolevulinic acid in urethral condylomata acuminate, Photochem. Photobiol., 2007, 83, 1069–1073.
M. Wainwright, Photodynamic antimicrobial chemotherapy (PACT), J. Antimicrob. Chemother., 1998, 42, 13–28.
G. Jori and S. B. Brown, Photosensitized inactivation of microorganisms, Photochem. Photobiol. Sci., 2004, 3, 403–405.
T. Dai, Y. Huang and M. R. Hamblin, Photodynamic therapy for localized infections–State of the art, Photodiagn. Photodyn. Ther., 2009, 6, 170–188.
R. F. Donnelly, P. A. McCarron and M. M. Tunney, Antifungal photodynamic therapy, Microbiol. Res., 2008, 163, 1–12.
M. Grinholc, B. Szramka, K. Olender and A. Graczyk, Bactericidal effect of photodynamic therapy against methicillin-resistant Staphylococcus aureus strain with the use of various porphyrin photosensitizers, Acta Biochim. Pol., 2007, 54, 665–670.
L. E. Bryld and G. B. Jemec, The bacterial flora of the skin surface following routine MAL-PDT, J. Dermatol. Treat., 2006, 17, 222–223.
T. H. Clayton and P. V. Harrison, Photodynamic therapy for infected leg ulcers, Br. J. Dermatol., 2007, 156, 384–385.
S. Motta and M. Monti, Photodynamic therapy–a promising treatment option for autoimmune skin ulcers: a case report, Photochem. Photobiol. Sci., 2007, 6, 1150–1151.
L. Bakos, G. Zoratto, L. Brunetto, N. Mazzotti and A. Cartell, Photodynamic therapy: a useful adjunct therapy for recalcitrant ulceration in pemphigus vulgaris, J. Eur. Acad. Dermatol. Venereol., 2009, 23, 599–600.
C. D. Enk, C. Fritsch, F. Jonas, A. Nasereddin, A. Ingber, C. L. Jaffe and T. Ruzicka, Treatment of cutaneous leishmaniasis with photodynamic therapy, Arch. Dermatol., 2003, 139, 432–434.
O. E. Akilov, S. Kosaka, K. O’Riordan and T. Hasan, Parasiticidal effect of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells, Exp. Dermatol., 2007, 16, 651–660.
A. Orenstein, J. S. Nelson, L. H. Liaw, R. Kaplan, S. Kimel and M. W. Berns, Photochemotherapy of hypervascular dermal lesions: a possible alternative to photothermal therapy?, Lasers Surg.Med., 1990, 10, 334–343.
S. Kimel, L. O. Svaasand, K. M. Kelly and J. S. Nelson, Synergistic photodynamic and photothermal treatment of port-wine stain?, Lasers Surg. Med., 2004, 34, 80–82.
Z. P. Qin, K. L. Li, L. Ren and X. J. Liu, Photodynamic therapy of port wine stains - a report of 238 cases, Photodiagn. Photodyn. Ther., 2007, 4, 53–59.
K. H. Yuan, Q. Li, W. L. Yu, D. Zeng, C. Zhang and Z. Huang, Comparison of photodynamic therapy and pulsed dye laser in patients with port wine stain birthmarks: A retrospective analysis, Photodiagn. Photodyn. Ther., 2008, 5, 50–57.
K. H. Yuan, Q. B. Huang and Z. Huang, Combination of PDT and topical angiogenic inhibitor for treatment of port wine stain (PWS) birthmarks–A novel approach, Proc. SPIE, 2009, 7380, 73802V1–73802V9.
M. Korbelik, Induction of tumor immunity by photodynamic therapy, J. Clin. Laser Med. Surg., 1996, 14, 329–334.
S. O. Gollnick, B. Owczarczak and P. Maier, Photodynamic therapy and anti-tumor immunity, Lasers Surg. Med., 2006, 38, 509–515.
A. P. Castano, P. Mroz and M. R. Hamblin, Photodynamic therapy and anti-tumour immunity, Nat. Rev. Cancer, 2006, 6, 535–545.
D. Nowis, T. Stokłosa, M. Legat, T. Issat, M. Jakóbisiak and J. Gołąb, The influence of photodynamic therapy on the immune response, Photodiagn. Photodyn. Ther., 2005, 2, 283–298.
Y. G. Qiang, C. M. Yow and Z. Huang, Combination of photodynamic therapy andimmunomodulation: current status and future trends, Med. Res. Rev., 2008, 28, 632–644.
U. R. Hengge and T. Ruzicka, Topical immunomodulation in dermatology: potential of toll-like receptor agonists, Dermatol. Surg., 2004, 30, 1101–1112.
E. Sotiriou, Z. Apalla, F. Maliamani, N. Zaparas, D. Panagiotidou and D. Ioannides, Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities, J. Eur. Acad. Dermatol. Venereol., 2009, 23, 1061–1065.
A. F. Nikkels, C. Pierard-Franchimont, N. Nikkels-Tassoudji, R. Bourguignon and G. E. Pierard, Photodynamic therapy and imiquimod immunotherapy for basal cell carcinomas, Acta. Clin. Belg., 2005, 60, 227–234.
V. Devirgiliis, V. Panasiti, M. Curzio, S. Gobbi, M. Rossi, V. Roberti and S. Calvieri, Complete remission of nodular basal cell carcinoma after combined treatment with photodynamic therapy and imiquimod 5% cream, Dermatol. Online J., 2008, 14, 25.
V. Madan, C. A. West, J.V. Murphy and J. T. Lear, Sequential treatment of giant basal cell carcinomas, J. Plast., Reconstr. Aesthetic Surg., 2009, 62, e368–372.
M. Shaffelburg, Treatment of actinic keratoses with sequential use of photodynamic therapy; and imiquimod 5% cream, J. Drugs Dermatol., 2009, 8, 35–39.
J. M. Ricart, J. Cordoba, M. Hernandez and I. Esplugues, Extensive genital bowenoid papulosis responding to imiquimod, J. Eur. Acad. Dermatol. Venereol., 2007, 21, 113–115.
W. Petrow, R. Gerdsen, M. Uerlich, O. Richter and T. Bieber, Successful topical immunotherapy of bowenoid papulosis with imiquimod, Br. J. Dermatol., 2001, 145, 1022–1023.
O. N. Richter, W. Petrow, E. Wardelmann, C. Dorn, M. Kupka and U. Ulrich, Bowenoid papulosis of the vulva-immunotherapeutical approach with topical imiquimod, Arch. Gynecol. Obstet., 2003, 268, 333–336.
X. L. Wang, H. W. Wang, M. X. Guo and Z. Huang, Combination of immunotherapy and photodynamic therapy in the treatment of Bowenoid papulosis, Photodiagn. Photodyn. Ther., 2007, 4, 88–93.
P. Hillemanns, X. Wang, S. Staehle, W. Michels and C. Dannecker, Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO2 laser vaporization, photodynamic therapy, excision and vulvectomy, Gynecol. Oncol., 2006, 100, 271–275.
U. Winters, S. Daayana, J. T. Lear, A. E. Tomlinson, E. Elkord, P. L Stern and H. C. Kitchener, Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia, Clin. Cancer Res., 2008, 14, 5292–5299.
S. Michel, M. Landthaler and U. Hohenleutner, Recurrence of portwine stains after treatment with the flashlamp-pumped pulsed dye laser, Br. J. Dermatol., 2000, 143, 1230–1234.
M. Huikeshoven, P. H Koster, C. A de Borgie, J. F Beek, M. J van Gemert and C. M van der Horst, Redarkening of port-wine stains 10 years after pulsed-dye-laser treatment, N. Engl. J. Med., 2007, 356, 1235–1240.
T. L. Phung, D. A Oble, W. Jia, L. E. Benjamin, M. C. Mihm Jr. and J. S. Nelson, Can the wound healing response of human skin be modulated after laser treatment and the effects of exposure extended? Implications on the combined use of the pulsed dye laser and a topical angiogenesis inhibitor for treatment of port wine stain birthmarks, Lasers Surg. Med., 2008, 40, 1–5.
C. J. Chang, Y. C. Hsiao, M. C. Mihm Jr. and J. S. Nelson, Pilot study examining the combined use of pulsed dye laser and topical imiquimod versus laser alone for treatment of port wine stain birthmarks, Lasers Surg. Med., 2008, 40, 605–610.
A. Ferrario, K. F. von Tiehl, N. Rucker, M. A Schwarz, P. S. Gill and C. J. Gomer, Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma, Cancer Res., 2000, 60, 4066–4069.
A. Frimpong-Boateng, A. Bunse, F. Rüfer and J. Roider, Photodynamic therapy with intravitreal application of triamcinolone acetonide in agerelated macular degeneration: functional results in 54 patients, Acta Ophthalmol., 2009, 87, 183–187.
P. K. Kaiser, Registry of Visudyne AMD TherapyWriting Committee; D. S. Boyer, R. Garcia, Y. Hao, M. S. Hughes, N. M. Jabbour, P. K. Kaiser, W. Mieler, J. S. Slakter, M. Samuel, M. J. Tolentino, D. Roth, T. Sheidow and H. A. Strong, Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration, Ophthalmology, 2009, 116, 747–755.
M. Korbelik, I. Cecic, S. Merchant and J. Sun, Acute phase response induction by cancer treatment with photodynamic therapy, Int. J. Cancer, 2007, 122, 1411–1417.
K. R. Suchin, A. J. Cucchiara, S. L. Gottleib, J. T. Wolfe, B. J. DeNardo, W. H. Macey, P. G. Bromley, C. C. Vittorio and A. H. Rook, Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution, Arch. Dermatol., 2002, 138, 1054–1060.
S. K. Richardson, J. H. Lin, C. C. Vittorio, E. J. Kim, J. S. Yoon, J. Junkins-Hopkins and A. H. Rook, High clinical response rate with multimodality immunomodulatory therapy for Sézary syndrome, Clin. Lymphoma Myeloma, 2006, 7, 226–232.
M. F. Naylor, W. R. Chen, T. K. Teague, L. A. Perry and R. E. Nordquist, In situ photoimmunotherapy: a tumour-directed treatment for melanoma, Br. J. Dermatol., 2006, 155, 1287–1292.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published as part of a themed issue on immunological aspects and drug delivery technologies in PDT.
Rights and permissions
About this article
Cite this article
Wang, XL., Wang, HW., Yuan, KH. et al. Combination of photodynamic therapy and immunomodulation for skin diseases—update of clinical aspects. Photochem Photobiol Sci 10, 704–711 (2011). https://doi.org/10.1039/c0pp00373e
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/c0pp00373e